FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes

Journal of Clinical Investigation

Volumn 111, Issue 5, 2003, Pages 627-637

  Honig, Shaun M ^a   Fu, Shuang ^a   Mao, Xia ^a   Yopp, Adam ^a   Gunn, Michael D ^b   Randolph, Gwendalyn J ^a   Bromberg, Jonathan S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BETA1 INTEGRIN; FINGOLIMOD; GLYCOPROTEIN P; HERMES ANTIGEN; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 1; PEPTIDOLEUKOTRIENE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; LYMPH NODE; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SPLEEN; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; CYSTEINE; IMMUNOSUPPRESSIVE AGENTS; LEUKOTRIENES; LYMPH NODES; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PHOSPHORYLATION; PROPYLENE GLYCOLS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHOLIPID; SPHINGOSINE; T-LYMPHOCYTES;

EID: 0037373333     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316200     Document Type: Article

References (47)

1. Pinschewer, D.D., et al. 2001. FTY720 immunosuppression impairs effector-T-cell peripheral homing without affecting induction, expansion, and memory. J. Immunol. 164:5761-5770.
2. Nagahara, Y., Ikekita, M., and Shinomiya, T. 2000. Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria. J. Immunol. 165:3200-3289.
3. Chiba, K., et al. 1998. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160:5037-5044.
4. Butcher, E.C., and Picker, L.J. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
5. Lakkis, F., Konieczny, B., and Inoue, Y. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-688.
6. Mandala, S., et al. 2002. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:346-349.
7. Randolph, G.J., et al. 1998. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatics. Proc. Natl. Acad. Sci. U. S. A. 95:6924-6929.
8. van Helvoort, A., et al. 1996. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87:507-517.
9. Raggers, R.J., Vogels, I., and van Meer, G. 2001. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem. 357:859-865.
10. Ernest, S., and Bello-Reuss, E. 1999. Secretion of platelet-activating factor is mediated by MDR1 P-glycoprotein in cultured human mesangial cells. J. Am. Soc. Nephrol. 10:2306-2313.
11. Leier, I., et al. 1994. The MRP1 gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269:27807-27810.
12. Raggers, R.J., van Helvoort, A., Evers, R., and van Meer, G. 1999. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell Sci. 112:415-422.
13. Robbiani, D.F., et al. 2000. The leukotriene C4 transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell. 103:757-768.
14. Randolph, G.J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13:267-274.
15. Robinson, S.D., et al. 1999. Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc. Natl. Acad. Sci. U. S. A. 96:11452-11457.
16. Chen, X.S., Sheller, J.R., Johnson, E.R., and Funk, C.D. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature. 372:179-181.
17. Schinkel, A.H., et al. 1997. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 94:4028-4033.
18. Lorcio,A., et al. 1998. Disruption of the murine MRP(multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of gluathione. Cancer Res. 57:5238-5242.
19. Nakano, H., et al. 1998. A novel gene mutant involved in T-lymphocyte-specific homing into peripheral lymphoid organs on mouse chromosome 4. Blood. 91:2886-2895.
20. Weninger, W., et al. 2000. Specialized contributions by α-fucosyl-transferase-IV and FucT-VII during leukocyte rolling in dermal microvessels. Immunity 12:665-676.
21. Jung, S., et al. 2000. Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114.
22. Brinkmann,V., et al. 2001. FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects. Transplant. Proc. 33:3078-3080.
23. Chaudhary, P.M., and Roninson, I.B. 1991. Expression and activity of p-glycoprotein, a multidrug efflux pump, in human hematopoetic stem cells. Cell. 66:85-94.
24. Lohoff, M., et al. 1998. A multidrug resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th)2 but not Th1 cells, and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Invest. 101:703-710.
25. Sikic, B.I. 1997. Pharmacologic approaches to reversing multidrug resistance. Semin. Hematol. 34:40-47.
26. Jones, T.R., et al. 1989. Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist. Can. J. Physiol. Pharmacol. 67:17-31.
27. Cifone, M.G., Cironi, L., Santoni, A., and Testi, R. 1995. Diacylglycerol lipase activation and 5-lipoxygenase activation and translocation following TCR/CD3 triggering in T cells. Eur. J. Immunol. 25:1080-1086.
28. Bai, Y., et al. 2002. L-selectin lymph node occupancy is required to induce alloantigen specific tolerance. J. Immunol. 168:1579-1589.
29. Lepault, F., Gangerault M.C., Faveeuw, C., and Boitard, C. 1994. Recirculation, phenotype, and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur. J. Immunol. 24:3106-3112.
30. Pachynski, R.K, Wu, S.W., Gunn, M.D., and Erle, D.J. 1998. Secondary lymphoid-tissue chemokine (SLC) stimulates integrin α4β7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1(MAdCAM-1) under flow. J. Immunol. 161:952-956.
31. Olivera, A., and Spiegel, S. 2001. Sphingosine kinase: a mediator of vital cellular functions. Prostaglandins Other Lipid Mediat. 64:123-134.
32. Mandala, S. 2001. Sphingosine-1-phosphate phosphatases. Prostaglandins Other Lipid Mediat. 64:143-156.
33. Mackay, C.R., Marston, W.L., and Dudler, L. 1990. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171:801-817.
34. Henning, G., et al. 2001. CC chemokine receptor 7-dependent and - independent pathways for lymphocyte homing: modulation by FTY720. J. Exp. Med. 194:1875-1881.
35. Reif, K., et al. 2002. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature. 416:94-99.
36. Gosling, J., et al. 2000. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 164:2851-2856.
37. Soto, H., et al. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. U. S. A. 95:8205-8210.
38. Nelson, P.J., and Krensky, A. 2001. Chemokines, chemokine receptors, and allograft rejection. Immunity. 14:377-386.
39. Witkowski, J.M., and Miller, R.A. 1993. Increased function of P-glycoprotein in T lymphocytes of aging mice. J. Immunol. 150:1296-1306.
40. Witkowski, J.M., Li, S.P., Gorgas, G., and Miller, R.A. 1994. Extrusion of the P-glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cells subsets that differ in IL-2 driven IL-4 production. J. Immunol. 153:658-665.
41. Gunn, M.D., et al. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189:451-460.
42. Parlato, S., et al. 2001. Expression of CCR7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells; importance for the rapid acquisition of potent migratory and functional activities. Blood. 98:3022-3029.
43. Sallusto, F., and Lanzavecchia, A. 2000. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177:134-140.
44. Goulet, G.L., et al. 2001. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. J. Immunol. 176:6631-6636.
45. Townsend, S.E., and Goodnow, C.C. 1998. Abortive proliferation on rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J. Exp. Med. 187:1611-1621.
46. Starzl, T.E., and Zinkernagel, R.M. 1998. Antigen localization and migration in immunity and tolerance. N. Engl. J. Med. 339:1905-1913.
47. Bromley, S.K., Peterson, D.A., Gunn, M.D., and Dustin, M.L. 2001. Hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J. Immunol. 165:15-19.